Allogeneic Hematopoietic Stem Cell Transplant Overcomes the Adverse Survival Effect of Very High Risk and Unfavorable Karyotype in Myelofibrosis
American Journal of Hematology - United States
doi 10.1002/ajh.25053
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 24, 2018
Authors
Publisher
Wiley